Company Overview
Snapshot
Founded in February 2017 by Harel Manor and Lauren Gorelick, Fibioseq Medical operates with 1–10 employees. The company has raised $1.73M across four funding rounds. In January 2019, the company secured Seed funding, advancing its development-stage solutions for wrist joint replacement.
Business overview
Fibioseq Medical is a development-stage company focused on improving patient care in total wrist implants within the Health Tech & Life Sciences sector. Its core product, WristArt, is a patented Total Wrist Arthroplasty implant designed to preserve the natural biomechanics of the joint, offering near-normal range of motion and simplifying surgical procedures. The company targets the global medical devices industry, serving surgeons and patients with innovative treatments and medical technologies.
Log in to access full profile ›Company Intelligence Q&A
- What is Fibioseq Medical's primary product?
- Fibioseq Medical's primary product is WristArt, a patented Total Wrist Arthroplasty implant designed to improve wrist joint replacement solutions by preserving natural biomechanics and providing near-normal range of motion.
- When was Fibioseq Medical founded?
- Fibioseq Medical was founded in February 2017.
- Who are the founders of Fibioseq Medical?
- Fibioseq Medical was co-founded by Harel Manor and Lauren Gorelick.
- What is the current stage of Fibioseq Medical's product development?
- Fibioseq Medical's WristArt product is currently in the Clinical Trial stage, focusing on improving patient care in total wrist implants.
- Has Fibioseq Medical received any grants?
- Yes, Fibioseq Medical received a grant from the Israel Innovation Authority in April 2018 and another in January 2020.